Omega-3 Fatty Acids: What the Evidence Shows for Weight and Metabolic Health

Omega-3 fatty acids are a family of polyunsaturated fats that play essential roles in cell membrane structure, inflammation regulation, and cardiovascular function. The three most clinically relevant forms are alpha-linolenic acid (ALA, found in plant sources), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) — the latter two found primarily in oily fish and marine algae. The UK government recommends eating at least two portions of fish per week, one of which should be oily, providing approximately 450mg of EPA and DHA per day.

What are the established benefits of omega-3s?

The cardiovascular benefits of EPA and DHA are among the most extensively studied in nutritional medicine. A 2019 randomised controlled trial published in the New England Journal of Medicine — the REDUCE-IT trial — found that high-dose EPA supplementation (4g per day) reduced major cardiovascular events by 25% in people with elevated triglycerides and established cardiovascular disease or diabetes. Omega-3s reduce triglycerides, lower blood pressure modestly, reduce platelet aggregation, and have anti-arrhythmic properties.

Do omega-3s directly support weight loss?

The evidence for a direct weight loss effect of omega-3 supplementation is modest. A 2020 meta-analysis in Obesity Reviews found that omega-3 supplementation produced small but statistically significant reductions in waist circumference (approximately 1.5cm) and body fat percentage, without significant effects on total body weight. The effect was more pronounced in people with metabolic syndrome and in studies using higher doses.

The mechanism may involve omega-3s effects on appetite-regulating hormones: EPA and DHA have been shown to increase GLP-1 and PYY secretion from gut cells, potentially enhancing satiety. They also reduce leptin resistance in animal models, though this effect is less clearly demonstrated in humans.

What about inflammation?

The anti-inflammatory effects of omega-3s are well established. EPA and DHA are precursors to resolvins and protectins — specialised pro-resolving mediators that actively resolve inflammation rather than simply suppressing it. In people with obesity, omega-3 supplementation consistently reduces circulating CRP, IL-6, and TNF-alpha. Given the central role of chronic inflammation in obesity-related disease, this is clinically meaningful even in the absence of large effects on body weight.

What are the best dietary sources?

• Oily fish: salmon, mackerel, sardines, herring, and trout are the richest sources of EPA and DHA
• Marine algae: the original source of EPA and DHA in the food chain; algae-based supplements are suitable for those who do not eat fish
• Walnuts and flaxseeds: rich in ALA, though conversion to EPA and DHA in the body is limited (typically less than 10%)

For personalised nutritional guidance as part of a doctor-led weight management programme, contact Weight Loss Wales today.